Alamar Biosciences Q3'26 Results Scheduled for Nov. 3
Alamar Biosciences is scheduled to report Q3'26 results after the market closes on Nov. 3. Revenue and EPS estimates were provided.
Related stories
BOJ to Sell ETF Holdings at About 0.1% of Market Trading Value
M impact | EQUITY | Oct 30, 2026, 03:03 AM UTC
Nikkei Futures Down 2.6% After BOJ Decision
Nikkei futures were last down 2.6%, largely unmoved by the BOJ decision.
M impact | EQUITY | Oct 30, 2026, 03:03 AM UTC
Asian session market picture: S&P 500 -0.99%, Nasdaq 100 -2.2%; USD/JPY -0.12%, WTI +1.28%, 1810 leads volume
Asian session market picture. US index futures: S and P futures is down 0.99 percent, Nasdaq futures is down 2.2 percent, Dow futures is down 0.16 percent and Russell futures is do
M impact | EQUITY | Oct 30, 2026, 03:00 AM UTC
Sarimelati Kencana Attributes Q3 2026 Net Profit Growth to Operating Efficiencies
M impact | EQUITY | Oct 30, 2026, 02:58 AM UTC
South Korea's Kospi Extends Losses, Down 5.3% at 5,622.84
M impact | EQUITY | Oct 30, 2026, 02:57 AM UTC
Nikkei Falls 3% as Technology Shares Slide on AI Concerns
The Nikkei fell 3% as technology shares declined amid concerns about artificial intelligence.
M impact | EQUITY | Oct 30, 2026, 02:50 AM UTC